Oramed Pharmaceuticals Inc. (ORMP): Gross Profit

Annual figures by period end, from SEC filings. For years the company left out, it is revenue minus cost of revenue, computed by TickerFacts; where both exist they agree (see each figure's source).

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Partial revenue. In this company's filings, net income for the year ended 2025-12-31 is larger than reported revenue. The revenue it tags covers only part of its income (banks and REITs often tag only fee income this way, leaving out interest or rent), so it is not the company's whole top line. Margins on it are not computed, and it is left out of revenue rankings.

$13.0K
Year ended 2025-12-31
$2.27M2016-08-31: $151.0K2017-08-31: $2.27M2025-12-31: $13.0K$13.0K
2016-08-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$13.0Kn/a2026-03-26, From 2025-01-01
No annual figure between 2017-08-31 and 2025-12-31.
2017-08-31$2.27Mn/m2019-11-27, From 2016-09-01
2016-08-31$151.0Kn/a2018-11-28, From 2015-09-01